Intuitive Surgical analyst raises eyebrows with new stock price target
This is what could happen next to Intuitive Surgical shares.
Jim Cramer wants answers.
The CNBC anchor and Mad Cash maven wants to snatch why Deutsche Bank modified into being so rough on Intuitive Surgical (ISRG) .
The investment firm downgraded the biotech to sell from withhold and slashed its stock brand aim to $440 from $515.
What's Your Reaction?
